| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb827766e457fe43360c5865a8f2e56b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4965 |
| filingDate |
2010-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b52522a95c7693b98da406e4a94b44e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d824c0212bca56466ea8ca4ded2f4f10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d76c018567af9367ac1f786978d6f95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f62f883a3704bd9592d3620fe9006b56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cdd78ca164353dff35d1d70046feebc |
| publicationDate |
2011-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2011009802-A |
| titleOfInvention |
OPHTHALMIC FORMULATIONS OF CETIRIZINE AND METHODS OF USE. |
| abstract |
The present invention provides stable topical formulations for cetirizine that provides a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and / or allergic conjunctivitis. The invention further provides methods for treating allergic conjunctivitis and / or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application directly to the eye of the cetirizine formulations of the invention. |
| priorityDate |
2009-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |